Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study
- PMID: 19011978
- PMCID: PMC3446202
- DOI: 10.1007/s10552-008-9259-x
Vaccination history and risk of non-Hodgkin lymphoma: a population-based, case-control study
Abstract
Objective: As factors that alter the immune system have been implicated in non-Hodgkin lymphoma (NHL) etiology, it is of interest to explore the association between vaccination and risk of NHL. Results of few epidemiologic studies conducted thus far are inconsistent, and only one has examined the association by histologic subtype.
Subjects: A population-based, case-control study of 387 patients with NHL and 535 controls conducted in Nebraska between 1999 and 2002.
Methods: Information on vaccination for tetanus, polio, influenza, smallpox, and tuberculosis, as well as important environmental factors, was collected by telephone interview. Risk was estimated by odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for confounders.
Results: We found that NHL risk was inversely associated with ever receiving a polio (OR = 0.59, CI = 0.40-0.87) or smallpox (OR = 0.71, CI = 0.51-0.98) vaccination, and positively associated with influenza vaccination (OR = 1.53, CI = 1.14-2.06). No significant association was found for tetanus or tuberculosis vaccination. The patterns of association were similar between men and women. Analysis by histologic subtypes showed that polio vaccination was associated with a lower risk of follicular (OR = 0.54, CI = 0.31-0.92) and chronic lymphocytic leukemia/small lymphocytic lymphomas (OR = 0.29, CI = 0.12-0.69) and smallpox vaccination was associated with a lower risk of marginal zone lymphoma (OR = 0.41, CI = 0.19-0.88). In contrast, ever receiving an influenza vaccination was associated with a higher risk of follicular (OR = 1.98, CI = 1.23-3.18) and diffuse large B cell lymphomas (OR = 1.88, CI = 1.13-3.12).
Conclusion: Risk of NHL is inversely associated with polio and smallpox vaccination and positively associated with influenza vaccination. These associations appear to differ by histologic subtype.
Similar articles
-
Obesity and risk of non-Hodgkin lymphoma (United States).Cancer Causes Control. 2007 Aug;18(6):677-85. doi: 10.1007/s10552-007-9013-9. Epub 2007 May 7. Cancer Causes Control. 2007. PMID: 17484069
-
Family history of hematopoietic malignancy and risk of lymphoma.J Natl Cancer Inst. 2005 Oct 5;97(19):1466-74. doi: 10.1093/jnci/dji293. J Natl Cancer Inst. 2005. PMID: 16204696
-
Dietary intake of fruit and vegetables and risk of non-Hodgkin lymphoma.Cancer Causes Control. 2011 Aug;22(8):1183-95. doi: 10.1007/s10552-011-9797-5. Epub 2011 Jun 22. Cancer Causes Control. 2011. PMID: 21695384
-
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph).Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):925-33. doi: 10.1158/1055-9965.EPI-04-0693. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15824165 Review.
-
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.Drugs. 2003;63(8):803-43. doi: 10.2165/00003495-200363080-00005. Drugs. 2003. PMID: 12662126 Review.
Cited by
-
Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunity.Eur J Clin Microbiol Infect Dis. 2019 Mar;38(3):449-456. doi: 10.1007/s10096-018-03449-z. Epub 2019 Feb 5. Eur J Clin Microbiol Infect Dis. 2019. PMID: 30719592
-
Influenza vaccines in immunosuppressed adults with cancer.Cochrane Database Syst Rev. 2013 Oct 29;2013(10):CD008983. doi: 10.1002/14651858.CD008983.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2018 Feb 01;2:CD008983. doi: 10.1002/14651858.CD008983.pub3. PMID: 24166741 Free PMC article. Updated.
-
Epstein-Barr virus reactivation after COVID-19 vaccination in a young immunocompetent man: a case report.Clin Exp Vaccine Res. 2022 May;11(2):222-225. doi: 10.7774/cevr.2022.11.2.222. Epub 2022 May 31. Clin Exp Vaccine Res. 2022. PMID: 35799871 Free PMC article.
-
Influenza vaccines in immunosuppressed adults with cancer.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD008983. doi: 10.1002/14651858.CD008983.pub3. Cochrane Database Syst Rev. 2018. PMID: 29388675 Free PMC article.
-
A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient.Transplant Proc. 2022 Jul-Aug;54(6):1575-1578. doi: 10.1016/j.transproceed.2021.09.006. Epub 2021 Sep 30. Transplant Proc. 2022. PMID: 34702598 Free PMC article.
References
-
- Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16:405–408. - PubMed
-
- Filipovich AH, Mathur A, Kamat D, Shapiro RS. Primary immunodeficiencies: genetic risk factors for lymphoma. Cancer Res. 1992;52:5465–5467. - PubMed
-
- Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980–2002. AIDS. 2006;20:1645–1654. - PubMed
-
- Goedert JJ. The epidemiology of acquired immunodeficiency syndrome malignancies. Seminars in Oncol. 2000;27:390–401. - PubMed
-
- Fisher SG, Fisher RI. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol. 2006;18:417–424. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials